What are the opening hours?

Monday 10am - 6pm Tuesday 7am - 5pm Wednesday 7am - 5pm Thursday 2pm - 10pm Friday 2pm - 10pm Saturday 10am - 5pm Sunday 6pm - 10pm

The Researcher OG

Home
United States
Santa Barbara, CA
The Researcher OG

Directions Website

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from The Researcher OG, Alternative & holistic health service, Santa Barbara, CA.

Mike Robinson, Researcher OG
Ask for a Free ECS Consult

Creator of Researcher®️ Genevieve's Dream™️ Nano Terps®️ Thermonoids®️ GENEVEX®️ Plant Chat®️ PREVENT®️ Get Balanced®️ NANO®️ Jane®️ & more

CEO Nanobles/Global Cannabinoid Research Center GCRC

10/25/2026

A 2026 brain-imaging study compares white-matter measures across cannabis, opioid, and ni****ne dependence and examines their relationship with impulsive choice. The researchers found differing patterns across the groups, supporting a more specific investigation of substance-related neurobiology.

White matter connects brain regions, and imaging measures can reveal its organization. Combining those observations with behavioral testing creates an opportunity to examine whether a particular pattern relates to a function relevant to treatment or daily life.

What I find constructive is the move away from treating every substance-use history as biologically identical. The cross-sectional design identifies relationships that need prospective follow-up to establish their direction and persistence. Future research can examine whether the measures change with recovery and whether they add useful information for care. That would help connect imaging research to practical goals such as improved decision-making, treatment engagement, and sustaining changes that matter to the person.

Mike Robinson, Global Cannabinoid Research Center

White matter signatures of addiction diverge across opioids, cannabis and ni****ne and predict impulsive choice in cannabis dependence (2026)

https://www.nature.com/articles/s41398-026-04491-8

10/24/2026

“Psilocybin and Inflammatory and Mitochondrial Stress Markers in Parkinson Disease: A Nonrandomized Clinical Trial” - October 2026

Psychedelic research keeps giving us reasons to look beyond changes in perception. I’m interested in what we can actually measure, especially when the conversation moves from how someone feels to what’s happening inside their biology.

In “Psilocybin and Inflammatory and Mitochondrial Stress Markers in Parkinson Disease,” researchers analyzed blood from nine people with Parkinson’s and mood dysfunction. Participants received two supervised psilocybin doses, approximately two weeks apart.

Their combined inflammation score fell after treatment and remained lower 30 days after the second dose. Some individual inflammatory markers improved early, but those changes weren’t consistently significant later. A marker associated with mitochondrial stress also decreased shortly after dosing, without a significant difference at the final follow-up.

That distinction matters. A lower blood-marker score doesn’t establish that inflammation inside the brain decreased, that neurons recovered, or that Parkinson’s progression slowed.

The study was small, open-label, and had no control group. Changes in stress, sleep, expectations, or other factors could have contributed, so we can’t assign the results to psilocybin alone.

What catches my attention is the opportunity to ask better questions. Could changes in mood and immune signaling influence each other? Could future controlled trials identify who benefits, how long changes last, and whether those changes improve daily life?

I want to see this followed carefully. Measuring the biology alongside the human experience gives us a much stronger foundation for understanding therapeutic potential.

Mike Robinson, Global Cannabinoid Research Center

https://doi.org/10.1001/jamapsychiatry.2026.2733

10/23/2026

Wake up, go for a walk and live your life to the fullest. Every day brings us a new adventure, and it should bring us more knowledge. Both of those two aspects are up to us.

Diversify your plant medicine intake - let’s have a talk about it!

10/23/2026

A 2026 systematic review brings together stroke-related cannabinoid research and experimental therapeutic evidence. It brings together experimental work on a condition in which interrupted blood flow triggers overlapping injury, immune, and recovery processes.

The ECS is relevant because its receptors and lipid mediators can influence communication among neurons, glia, and immune cells. Studying these components across the injury-to-recovery timeline lets researchers assess which interventions have the strongest rationale at each stage.

I'm interested in the chance to improve precision in an area where timing has major consequences. An effective stroke strategy must consider tissue exposure, treatment windows, and functional recovery alongside molecular changes. This review provides a framework for examining preclinical evidence and identifying the most important gaps to address next. I want future studies to link target-specific findings to reproducible neurological outcomes, helping the field develop a more practical understanding of endocannabinoid-related recovery biology.

Mike Robinson, Global Cannabinoid Research Center

Cannabinoid receptors and neuroinflammation in ischemic stroke: A systematic review (2026)

https://apb.tbzmed.ac.ir/Article/apb-46785

10/23/2026

So many people that I work with that have high THC tolerances have one thing in common, they lack planned exercise in their life. It takes a commitment and time, I'll walk on my treadmill while pushing content as it's easy to do and I'm exercising. My AM routine is often 2+ miles of Nordic Walking. Get Balanced! Let's talk...

10/22/2026

A clinical-pharmacology preprint examines what it would take to run an interpretable C*D study for chronic neuroinflammation. It focuses on the relationship between the treatment given, the exposure achieved, and the biological outcome researchers hope to measure.

This is an important development question because researchers study brain inflammation through several different signals and methods. A useful trial needs a well-characterized preparation, an appropriate treatment period, and measurements that show whether the proposed target process changed.

I see real value in improving those foundations; strong trial design gives a promising compound a fair assessment and makes the result more useful for the next research group. This preprint is best approached as a contribution to study planning, with its specific proposals needing careful comparison with existing evidence. I would like to see clinical programs connect C*D exposure with target-related biology and outcomes that matter to participants, so each trial answers a more useful question.

Mike Robinson, Global Cannabinoid Research Center

Cannabidiol for chronic neuroinflammation: clinical pharmacology and what an interpretable trial will require (2026)

https://www.authorea.com/doi/pdf/10.22541/authorea.15009897

10/21/2026

A 2026 mouse experiment explores the conversation between cannabinoid and cholinergic signaling in anxiety-like behavior. Researchers compared direct CB1 and CB2 modulation with indirect approaches involving the endocannabinoid-degrading enzymes FAAH and MAGL during responses to cholinergic drugs.

This creates a useful experimental framework because multiple signaling systems contribute to emotional behavior simultaneously. Comparing receptor-directed compounds with enzyme inhibitors can help determine whether different routes of ECS modulation produce similar or distinct outcomes.

What draws my attention is the interaction between systems: a compound can enter biology through one target and produce a response shaped by the state of another pathway, which is why context deserves measurement. This animal work supports further investigation of targeted anxiolytic mechanisms, with the behavioral findings interpreted alongside drug selectivity and experimental conditions. The positive direction offers a more detailed understanding of which signal combinations support adaptive responses and how researchers can study them reproducibly.

Mike Robinson, Global Cannabinoid Research Center

Effects of Endocannabinoid System Modulation on Cholinergic-Induced Anxiety-like Behaviors in Mice (2026)

https://www.mdpi.com/1424-8247/19/10/1574

10/21/2026

Your Cannabis Success Story:
Have you told it? Let's put it in print, educate others and let the world know how the plant heals.

10/20/2026

A research overview of metabolic syndrome takes the ECS beyond the familiar discussion of appetite and into glucose handling, lipid storage, pancreatic function, and inflammation. It describes the endocannabinoidome as an expanded network involving AEA, 2-AG, metabolic enzymes, and several interacting receptor systems.

The discussion includes CB1, CB2, TRPV1, GPR55, and PPAR pathways, each contributing different regulatory possibilities. In metabolic disease, the pattern and location of signaling become important because excessive activity in one pathway can coexist with a useful role for another.

For me, this is where the idea of balance becomes a research question with measurable parts. Researchers can study tissue exposure, lipid production, receptor response, and inflammatory state separately rather than bundling them into one general claim. The review points toward more targeted work on obesity, diabetes, and metabolic liver disease. Its value is a broader mechanistic map that can help researchers choose interventions according to the actual biology they hope to influence.

Mike Robinson, Global Cannabinoid Research Center

Sistema endocanabinoide y síndrome metabólico (2026)

https://revistasad.com/index.php/diabetes/article/view/1439

Address

Santa Barbara, CA

Opening Hours

Monday	10am - 6pm
Tuesday	7am - 5pm
Wednesday	7am - 5pm
Thursday	2pm - 10pm
Friday	2pm - 10pm
Saturday	10am - 5pm
Sunday	6pm - 10pm

Website

http://Researcher.O.G/, https://GlobalCannabinoidRC.com/, https://GenevievesDream.com/

Alerts

Be the first to know and let us send you an email when The Researcher OG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.